Katrine Bosley, President and CEO at Editas Medicine, Inc. (EDIT), sold 24,000 shares at $29.95 ($724K) on 2018-08-20, disclosed to the SEC on 2018-08-22.
Open-market sale of $724k EDIT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.95 | 6,567 | $197K | 27.2% |
| 2 | $29.95 | 6,567 | $197K | 27.2% |
| 3 | $30.43 | 5,433 | $165K | 22.8% |
| 4 | $30.43 | 5,433 | $165K | 22.8% |
| Total | $30.17 avg | 24,000 | $724K | 100% |
| Filing → |
| EDIT | SELL | 2018-11-05 | $323K | — | Filing → |
| EDIT | SELL | 2018-10-03 | $745K | — | Filing → |
| EDIT | SELL | 2018-09-06 | $736K | — | Filing → |